Follow us

Follow us

Innovative Research@HKBU

Excellence . Innovation . Whole Person Education

HKBU leads interdisciplinary and inter-institutional research on Alzheimer’s Disease

Studio-047-Edit

Here are the project team members from HKBU:
(From left, second row) Dr Li Hung-wing and Professor Ricky MS Wong of the Department of Chemistry; Professor Ken Yung from the Department of Biology; Dr Durairajan S S Kumar of the School of Chinese Medicine
(From left, first row) Dr Daniel Kwong of the Department of Chemistry; Professor Bian Zhaoxiang of the School of Chinese Medicine

Professor Ricky Man-shing Wong of the Department of Chemistry is leading an interdisciplinary and inter-institutional research project entitled “Alzheimer’s Disease: From Detection, Diagnostics to Therapeutics” in collaboration with the Chinese University of Hong Kong.

Recently awarded the Collaborative Research Fund (CRF) 2015/16 of the Research Grants Council, the project will pull together expertise in organic, analytical, biophysical chemistry, biomedical and neuroscience to tackle the unmet early detection, diagnostic and therapeutic challenges in the treatment of Alzheimer’s Disease.

Here is the project summary from Professor Wong, the Project Co-ordinator:

CRF Project Title: Alzheimer’s Disease: From Detection, Diagnostics to Therapeutics

Project Coordinator: Professor Ricky Man-shing Wong, Hong Kong Baptist University

Summary: Alzheimer’s disease (AD) is the most prevalent form of dementia, which leads to an impairment of many cognitive functions and memory loss. According to the Alzheimer’s Association, AD was estimated to be affecting 44 million people worldwide in 2013 (9.2 million in China) and the patient number is expected to be 135 million by 2050, causing an enormous health care cost and burden associated with this disease. An interdisciplinary and inter-institutional research team with expertise in organic, analytical, biophysical chemistry, biomedical and neuroscience has been assembled to tackle the unmet early detection, diagnostic and therapeutic challenges in AD treatment. Advancement in these strategies would significantly relieve the global burden of the disease. We foresee future collaboration among academic, health and medical institutes, industry and commercial organizations will be facilitated and established upon the completion of this project for ultimate AD treatment benefits. In short, the success of this broad program certainly brings a new vista and new scientific knowledge as well as high impact on the development of novel drugs and medical diagnosis for AD and other related neurodegenerative diseases.

Illustration for CRF project_GS

About Collaborative Research Fund – Group Research Grant

Run by the Research Grants Council, the initiative is intended to encourage research groups in UGC-funded institutions to engage in collaborative research across disciplines and/or across institutions with a view to enhancing the research output of institutions in terms of the level of attainment, quantity, dimensions and/or speed.